GR 60139
Latest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 30 May 1997 No-Development-Reported for Ischaemic heart disorders in Italy (Unknown route)
- 02 Mar 1995 Preclinical development for Ischaemic heart disorders in Italy (Unknown route)